Literature DB >> 35125720

Utility of International Society on Thrombosis and Hemostasis Bleeding Assessment Tool (ISTH-BAT) in Patients with Inherited Bleeding Disorders: A Cross-Sectional Study from Southern India.

Pagadalu Lokababu Ambika1, Debdatta Basu1, Sukesh Chandran Nair2, Rakhee Kar1.   

Abstract

The International Society on Thrombosis and Hemostasis bleeding assessment tool (ISTH-BAT) was developed to record bleeding symptoms and aid in patient diagnosis. This study was done to investigate the utility of ISTH-BAT in patients suspected to have inherited bleeding disorders. This cross-sectional study was conducted in a tertiary care hospital in Southern India over 3 and 1/2 years. A trained investigator administered the ISTH-BAT questionnaire to 432 patients undergoing evaluation for inherited bleeding disorder prior to routine coagulation screening and confirmatory tests and to 131 healthy volunteers as controls. Among patients, 42(9.7%) had primary hemostatic defect, 150(34.7%) had secondary hemostatic defects and 229(53%) had normal screening coagulogram with mean bleeding scores (BS) being 5.9, 6.9, and 4.2 respectively and the proportion of patients with abnormal BS being 69%, 88.7% and 59.4% respectively; the latter qualifying as unknown hemostatic defect. 11(2.5%) with acquired hemostatic defect on workup were excluded. The mean BS was 1.52 among healthy volunteers. Common bleeding patterns were epistaxis (73.8%), cutaneous bleeding (52.4%), hematuria (54.8%), menorrhagia (50%) in primary hemostatic defect; cutaneous bleeding (72%), muscle hematoma (58.7%), hemarthrosis (46.7%), menorrhagia (58.7%) in secondary hemostatic defects and epistaxis (45.9%), cutaneous bleeding (62.4%), menorrhagia (30.7%) in normal screening coagulogram group. Grade of bleeding was mostly 2 and sometimes 4 in primary, 2-4 in secondary and 1-2 in normal screening coagulogram group. ISTH-BAT is a valuable tool to record lifelong bleeding history. The pattern and score give clues regarding the nature and severity of the bleeding disorder. © Indian Society of Hematology and Blood Transfusion 2021.

Entities:  

Keywords:  Bleeding assessment tool; Bleeding history; Bleeding score; ISTH-BAT; Inherited bleeding disorders; Normal screening coagulogram; Primary hemostatic defect; Unknown hemostatic defect

Year:  2021        PMID: 35125720      PMCID: PMC8804127          DOI: 10.1007/s12288-021-01435-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  21 in total

1.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors:  A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Authors:  F Rodeghiero; A Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 3.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 4.  Bleeders, bleeding rates, and bleeding score.

Authors:  A Tosetto; G Castaman; F Rodeghiero
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

5.  The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease.

Authors:  Augusto B Federici; Paolo Bucciarelli; Giancarlo Castaman; Maria G Mazzucconi; Massimo Morfini; Angiola Rocino; Mario Schiavoni; Flora Peyvandi; Francesco Rodeghiero; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2014-04-30       Impact factor: 22.113

6.  High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.

Authors:  Teresa Quiroga; Manuela Goycoolea; Olga Panes; Eduardo Aranda; Carlos Martínez; Sabine Belmont; Blanca Muñoz; Pamela Zúñiga; Jaime Pereira; Diego Mezzano
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

7.  Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.

Authors:  A Tosetto; G Castaman; I Plug; F Rodeghiero; J Eikenboom
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

Review 8.  Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management.

Authors:  Will Thomas; Kate Downes; Michael J R Desborough
Journal:  Haemophilia       Date:  2020-10-23       Impact factor: 4.287

9.  High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB).

Authors:  J Gebhart; S Hofer; S Panzer; P Quehenberger; R Sunder-Plassmann; G Hoermann; E Eigenbauer; H Haslacher; S Kepa; P A Kyrle; S Eichinger; P Knöbl; L Eischer; C Mannhalter; C Ay; I Pabinger
Journal:  Haemophilia       Date:  2018-02-01       Impact factor: 4.287

10.  Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders.

Authors:  Marcel Adler; Jonas Kaufmann; Lorenzo Alberio; Michael Nagler
Journal:  J Thromb Haemost       Date:  2019-05-22       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.